Enrofloxacin tab 150 mg

Enrofloxacin tab 150 mg
Product Description

Brand name is Gyroflox. It is used in the treatment of diseases associated with bacteria susceptible to enrofloxacin.

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator

More Products from Indian Immunologicals Ltd (56)

  • Bovoplex CC

    Product Bovoplex CC

    A dark brown injectable solution containing B complex, Vitamins, Liver Extract and Choline Chloride. It is primarily used as supportive therapy in conditions leading to liver Dysfunction viz. liver fluke infestation, fatty degeneration of liver, in the treatment of anorexia and B complex Vitamin deficiency...
  • Bruvax  Brucella vaccine S19  (available in eye drops as well)

    Product Bruvax Brucella vaccine S19 (available in eye drops as well)

    Light yellow flakes containing live Brucella abortus strain 19 bacteria in freeze driedpowder. Each dose contains not less than 40 x 10 9 organisms
  • Bruvax Rev-1

    Product Bruvax Rev-1

    Brucella Melitensis (strain rev-1) vaccine, living composition: Each dose contains Brucella melitensis strain rev.1 not less than 0.5X109 and not more than 4 X109 live bacteria, sucrose, enzymatic casein hydrolysate and sodium glutamate added as stabilizers. sterile diluent composition: disodium hydrogen...
  • Buparvaqone 100mg

    Product Buparvaqone 100mg

    Buparvaqone is a effective formulation used against Theileriosis and other theileriosis species.
  • Combined clostridium perfringens and tetanus vaccine, inactivated

    Product Combined clostridium perfringens and tetanus vaccine, inactivated

    combined clostridium perfringens and tetanus vaccine, inactivated composition: Each dose of 2mL contains: clostridium perfringens antigen type D ≥ 5 IU, tetanus toxoid antigen ≥ 2.5 units, thiomersal B.P ≤ 0.02% w/v as preservative, 2% w/v aluminium hydroxide gel ≤ 0.3mL and 0.85% w/v saline q.s
  • Cysvax

    Product Cysvax

    recombinant porcine cysticercosis vaccine Each dose of 1mL contains: taenia solium onchosphere antigen (TSOL 18) ≥ 150µg, thiomersal B.P. ≤ 0.02% w/v as preservative and mineral oil and phosphate buffer q.s to 1mL
  • Enrofloxacin tab 50 mg

    Product Enrofloxacin tab 50 mg

    Brand name is Gyroflox. It is used in the treatment of diseases associated with bacteria susceptible to enrofloxacin.
  • Fenbendazole  Tab. 150mg
  • Fenbendazole  Tab.1500mg
  • Foot and mouth disease concentrate bulk antigen serotype A- inactivated (for export purpose)

    Product Foot and mouth disease concentrate bulk antigen serotype A- inactivated (for export purpose)

    composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s
  • Foot and mouth disease concentrate bulk antigen serotype Asia-1 - inactivated (for export purpose)

    Product Foot and mouth disease concentrate bulk antigen serotype Asia-1 - inactivated (for export purpose)

    composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s

Indian Immunologicals Ltd resources (2)

  • News COVID-19 VACCINE DEVELOPMENT

    Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

    Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.